PATENT CLAIM ANALYSIS

Application Number: 15938292
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "269000"]

Abstract:
Provided are compounds and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with potassium channels.

Claim (Index 12):
The method of  claim 10 , wherein the disease or condition is selected from a neurodegenerative disease, dementia, heart disease, withdrawal symptoms associated with termination of addiction, metabolic disease, and bladder disease.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15877910', '15799771', '14454227', '14442838', '13418737']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7029987161062803
- 35 USC 102 Novelty (BERT): 0.5193592939025201
- Combined Prediction Score: 0.6846347738859043
- Mean Citation Score: 175.680896
- Max Citation Score: 225.2037
- Similarity Product: 130.76415966469645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test